Barclays analyst Lauren Lieberman lowered the firm’s price target on Colgate-Palmolive to $77 from $80 and keeps an Equal Weight rating on the shares. The analyst came away from Colgate’s Q4 results with "several questions," mostly around North America and gross margins. For a company that has a "focused portfolio" and is supposed to be a "recessionary beneficiary," things are beginning to feel a bit more complex, the analyst tells investors in a research note.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CL:
- Early notable gainers among liquid option names on January 30th
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Colgate-Palmolive names Steve Cahillane to Board of Directors
- Colgate-Palmolive price target lowered to $84 from $87 at Deutsche Bank
- Colgate-Palmolive upgraded to Overweight from Equal Weight at Morgan Stanley
Questions or Comments about the article? Write to editor@tipranks.com